Crystal structures of the disease-causing D444V mutant and the relevant wild type human dihydrolipoamide dehydrogenase

Szabo, E [Szabó, Eszter (biokémia), author] MTA-SE Research Group Neuro biochemical (SU / FM / I / DMB); Mizsei, R [Mizsei, Réka (szerkezeti biokémia), author] Department of Medical Biochemistry (SU / FM / I); Wilk, P; Zambo, Z [Zámbó, Zsófia Melinda (biokémia), author] Department of Medical Biochemistry (SU / FM / I); Torocsik, B [Törőcsik, Beáta (orvosi biokémia), author] MTA-SE Research Group Neuro biochemical (SU / FM / I / DMB); Weiss, MS; Adam-Vizi, V [Ádám, Veronika (idegtudomány, bio...), author] MTA-SE Research Group Neuro biochemical (SU / FM / I / DMB); Ambrus, A ✉ [Ambrus, Attila (Biokémia), author] MTA-SE Research Group Neuro biochemical (SU / FM / I / DMB)

English Article (Journal Article) Scientific
  • SJR Scopus - Biochemistry: Q1
Subjects:
  • Biochemistry and molecular biology
  • Biological sciences
  • Clinical medicine
We report the crystal structures of the human (dihydro)lipoamide dehydrogenase (hLADH, hE3) and its disease-causing homodimer interface mutant D444V-hE3 at 2.27 and 1.84 Å resolution, respectively. The wild type structure is a unique uncomplexed, unliganded hE3 structure with the true canonical sequence. Based on the structural information a novel molecular pathomechanism is proposed for the impaired catalytic activity and enhanced capacity for reactive oxygen species generation of the pathogenic mutant. The mechanistic model involves a previously much ignored solvent accessible channel leading to the active site that might be perturbed also by other disease-causing homodimer interface substitutions of this enzyme. © 2018 Elsevier Inc.
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2026-06-06 19:25